FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)

View source ↗

Summary

FDA approved a supplemental application for pravastatin sodium from Cipla USA Inc., authorizing changes to the existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)